ARCT Q1 2020 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-39.2% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$9M-357.6% margin

Net Income

-$10M-369.5% margin

EPS (Diluted)

$-0.67

QoQ Revenue Growth

-10.8%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$849,000

Balance Sheet

Total Assets

$72M

Total Liabilities

$55M

Stockholders' Equity

$17M

Cash & Equivalents

$59M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-39.2%
Gross Profit	$3M	-$3M	+189.0%
Operating Income	-$9M	-$7M	-45.4%
Net Income	-$10M	-$7M	-42.0%